Nenutil R - Search Results

1

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.

Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B. Hrstka R, et al. Among authors: nenutil r. Oncogene. 2010 Aug 26;29(34):4838-47. doi: 10.1038/onc.2010.228. Epub 2010 Jun 7. Oncogene. 2010. PMID: 20531310

2

A panel of monoclonal antibodies to keratin no. 7: characterization and value in tumor diagnosis.

Vojtĕsek B, Stasková Z, Nenutil R, Bártková J, Kovarík J, Rejthar A, Bártek J. Vojtĕsek B, et al. Among authors: nenutil r. Neoplasma. 1990;37(3):333-42. Neoplasma. 1990. PMID: 1695327

3

Monoclonal antibodies recognizing different epitopes of cytokeratin No.18.

Vojtĕsek B, Stasková Z, Nenutil R, Lauerová L, Kovarík J, Rejthar A, Bártková J, Bártek J. Vojtĕsek B, et al. Among authors: nenutil r. Folia Biol (Praha). 1989;35(6):373-82. Folia Biol (Praha). 1989. PMID: 2483834

4

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

Vojtesek B, Kovarik J, Dolezalova H, Nenutil R, Havlis P, Brentani RR, Lane DP. Vojtesek B, et al. Among authors: nenutil r. Br J Cancer. 1995 Jun;71(6):1253-6. doi: 10.1038/bjc.1995.242. Br J Cancer. 1995. PMID: 7779720 Free PMC article.

5

p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancer.

Vojtĕsek B, Kovarík J, Nenutil R, Svitáková M, Zaloudík J, Dolezalová H, Rejthar A, Lauerová L. Vojtĕsek B, et al. Among authors: nenutil r. Neoplasma. 1995;42(6):331-6. Neoplasma. 1995. PMID: 8592576

6

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

Lichnovský V, Kolár Z, Murray P, Hlobilková A, Cernochová D, Pospísilová E, Vojtĕsek B, Nenutil R. Lichnovský V, et al. Among authors: nenutil r. Mol Pathol. 1998 Jun;51(3):131-7. doi: 10.1136/mp.51.3.131. Mol Pathol. 1998. PMID: 9850335 Free PMC article.

7

New monoclonal antibodies recognizing p53 protein phosphorylated by casein kinase II at serine 392.

Pospísilová S, Kanková K, Svitáková M, Nenutil R, Vojtesek B. Pospísilová S, et al. Among authors: nenutil r. Folia Biol (Praha). 2001;47(4):148-51. Folia Biol (Praha). 2001. PMID: 11508859 No abstract available.

8

New monoclonal antibodies recognizing the p53 tumour suppressor protein homologue p73.

Cesková P, Nenutil R, Bray S, Svitáková M, Babcanová S, Uldrijan S, Vojtesek B. Cesková P, et al. Among authors: nenutil r. Folia Biol (Praha). 2001;47(6):211-4. Folia Biol (Praha). 2001. PMID: 11768779 No abstract available.

9

Differential expression of p73alpha in normal ectocervical epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma.

Nenutil R, Ceskova P, Coates PJ, Nylander K, Vojtesek B. Nenutil R, et al. Int J Gynecol Pathol. 2003 Oct;22(4):386-92. doi: 10.1097/01.pgp.0000092133.88121.98. Int J Gynecol Pathol. 2003. PMID: 14501821

10

[Relevance of p53 protein and its mutations for novel strategies in cancer therapy].

Müller P, Nenutil R, Vojtĕsek B. Müller P, et al. Among authors: nenutil r. Cas Lek Cesk. 2004;143(5):313-7. Cas Lek Cesk. 2004. PMID: 15305766 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters